Rangwala Reshma 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Rangwala Reshma（CIK 1825322）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-05-15）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 买入 | 947 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 卖出 | 408 | $3,876 |
| 2026-04-22 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 卖出 | 449 | $4,014 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 卖出 | 5,066 | $47,671 |
| 2026-02-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 买入 | 32,415 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 买入 | 945 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 卖出 | 408 | $2,623 |
| 2025-04-24 | Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Medical Officer | 卖出 | 419 | $2,585 |
来源：SEC Form 4 申报文件 · 截至 2026-05-15